Get the Stockscreener App
86.28
1.90%
1.61
After Hours:
86.28
Lemaitre Vascular Inc stock is traded at $86.28, with a volume of 184.02K.
It is up +1.90% in the last 24 hours and up +1.37% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
See More
Previous Close:
$84.67
Open:
$84.47
24h Volume:
184.02K
Relative Volume:
0.88
Market Cap:
$1.89B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
47.15
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
+6.05%
1M Performance:
+1.37%
6M Performance:
-3.80%
1Y Performance:
+36.87%
1-Day Range:
$83.75
$86.99
1-Week Range:
$79.95
$86.99
52-Week Range:
$62.39
$109.58
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
86.28 | 1.89B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
482.74 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.71 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
92.54 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
212.91 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.51 | 15.75B | 3.90B | 392.30M | 288.10M | 1.95 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Townsquare Capital LLC Buys 7,053 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
84,517 Shares in LeMaitre Vascular, Inc. (NASDAQ:LMAT) Purchased by Rockefeller Capital Management L.P. - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Federated Hermes Inc. - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Arrowstreet Capital Limited Partnership - MarketBeat
Envestnet Asset Management Inc. Buys 16,886 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Stock Holdings Increased by JPMorgan Chase & Co. - MarketBeat
(LMAT) Trading Advice - news.stocktradersdaily.com
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & ConsumablesSpecialty Stocks - Yahoo Finance
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Bought by Alliancebernstein L.P. - Defense World
F M Investments LLC Lowers Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Russell Investments Group Ltd. Sells 54,184 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Ranger Investment Management L.P. Has $60.65 Million Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Geode Capital Management LLC Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
JPMorgan Chase & Co. Boosts Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular (NASDAQ:LMAT) Stock Price Down 10.5%Time to Sell? - MarketBeat
Does LeMaitre Vascular (NASDAQ:LMAT) Have A Healthy Balance Sheet? - simplywall.st
LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock? - Yahoo Finance
Integrated Quantitative Investments LLC Purchases New Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Relative Strength Alert For LeMaitre Vascular - Nasdaq
Vanguard Group Inc. Purchases 1,846 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by DF Dent & Co. Inc. - MarketBeat
LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 - GlobeNewswire
LeMaitre Earnings Alert: Key Q1 2025 Results Coming May 1Mark Your Calendar - Stock Titan
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
KLP Kapitalforvaltning AS Acquires Shares of 8,800 LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues - TradingView
Sei Investments Co. Has $8.92 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Commonwealth Equity Services LLC Has $718,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Vascular Patches Market Future Business Opportunities - openPR.com
LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewswire
LeMaitre Vascular Set to Reveal Growth Strategy at Major Healthcare Conference - Stock Titan
Quantbot Technologies LP Sells 5,550 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
Segall Bryant & Hamill LLC Acquires New Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) - MarketBeat
2 Reasons to Avoid LMAT and 1 Stock to Buy Instead - The Globe and Mail
Thrivent Financial for Lutherans Sells 242 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT) - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Purchased by Sei Investments Co. - Defense World
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
3.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):